These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7463329)
1. Bioavailability and pharmacokinetics of a new, slow-release potassium chloride capsule. Arnold J; Jacob JT; Riley B J Pharm Sci; 1980 Dec; 69(12):1416-8. PubMed ID: 7463329 [TBL] [Abstract][Full Text] [Related]
2. Bioavailability and pharmacokinetics of a new sustained-release potassium chloride tablet. Betlach CJ; Arnold JD; Frost RW; Leese PT; Gonzalez MA Pharm Res; 1987 Oct; 4(5):409-11. PubMed ID: 3508550 [TBL] [Abstract][Full Text] [Related]
4. Bioavailability of potassium from three dosage forms: suspension, capsule, and solution. Melikian AP; Cheng LK; Wright GJ; Cohen A; Bruce RE J Clin Pharmacol; 1988 Nov; 28(11):1046-50. PubMed ID: 3243918 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and effects on fecal blood loss of a controlled release potassium chloride tablet. Tannen RL; Cordano A J Pharmacol Exp Ther; 1978 Jan; 204(1):240-6. PubMed ID: 304099 [TBL] [Abstract][Full Text] [Related]
6. A single blind normal volunteer bioavailability study of a new microencapsulated potassium chloride tablet compared with two reference potassium formulations. Caplain H; Dahan R; Pamphile R; Thebault JJ Eur J Drug Metab Pharmacokinet; 1991; 16(3):241-4. PubMed ID: 1814742 [TBL] [Abstract][Full Text] [Related]
7. A multiple-dose study of sustained-release theophylline and aminophylline. Meyer MC; Straughn AB; Lieberman P Chest; 1980 Aug; 78(2):300-3. PubMed ID: 7398417 [TBL] [Abstract][Full Text] [Related]
8. Bioequivalence of a slow-release potassium tablet and a liquid potassium supplement. Lowance DC; Murad F; Darrow WR; Bonus L Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):204-8. PubMed ID: 7095919 [TBL] [Abstract][Full Text] [Related]
9. [Relative bioavailability of effervescent tablet of potassium chloride in healthy volunteers]. Ma YM; Qiu FR; Mao GG; Zeng ZH; Chen B; Sun H Yao Xue Xue Bao; 2001 Sep; 36(9):699-702. PubMed ID: 12580112 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin. Binnion PF J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789 [TBL] [Abstract][Full Text] [Related]
11. Papaverine hydrochloride: the evaluation of two new dosage forms. Arnold JD; Baldridge J; Riley B; Brody G Int J Clin Pharmacol Biopharm; 1977 May; 15(5):230-3. PubMed ID: 326689 [TBL] [Abstract][Full Text] [Related]
12. Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers. Adjei A; Teuscher NS; Kupper RJ; Chang WW; Greenhill L; Newcorn JH; Connor DF; Wigal S J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):570-8. PubMed ID: 25514542 [TBL] [Abstract][Full Text] [Related]
13. Liquid and solid potassium chloride: bioavailability and safety. Skoutakis VA; Acchiardo SR; Wojciechowski NJ; Carter CA Pharmacotherapy; 1984; 4(6):392-7. PubMed ID: 6514589 [TBL] [Abstract][Full Text] [Related]
14. Impact of Formulation on the Pharmacokinetics of Dutasteride: Results from Two Phase I Studies. Fossler M; Zhu J; Roehrborn C; McAleese P; Manyak M Clin Drug Investig; 2016 Sep; 36(9):763-767. PubMed ID: 27356530 [TBL] [Abstract][Full Text] [Related]
15. Suprofen sustained release kinetics in healthy male volunteers. 1st communication: a single dose open crossover bioavailability study of suprofen sustained release tablets versus capsules. Michos N; Zulliger HW; Barkworth MF; Johnson KJ; Rehm KD; Töberich H; Klein G Arzneimittelforschung; 1986 Jun; 36(6):941-8. PubMed ID: 3741528 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic assessment of Slow-K and K-tab potassium chloride formulations in hypertensive patients treated with thiazide diuretics. Skoutakis VA; Carter CA; Acchiardo SR Drug Intell Clin Pharm; 1987 May; 21(5):445-50. PubMed ID: 3556129 [TBL] [Abstract][Full Text] [Related]
17. Nifedipine: kinetics and dynamics in healthy subjects. Kleinbloesem CH; van Brummelen P; van de Linde JA; Voogd PJ; Breimer DD Clin Pharmacol Ther; 1984 Jun; 35(6):742-9. PubMed ID: 6734025 [TBL] [Abstract][Full Text] [Related]
18. Theophylline bioavailability following chronic dosing of an elixir and two solid dosage forms. Shen DD; Fixley M; Azarnoff DL J Pharm Sci; 1978 Jul; 67(7):916-9. PubMed ID: 660507 [TBL] [Abstract][Full Text] [Related]
19. Bioavailability of potassium from controlled-release tablets with and without water loading. Bechgaard H; Shephard NW Eur J Clin Pharmacol; 1981; 21(2):143-7. PubMed ID: 7341281 [TBL] [Abstract][Full Text] [Related]
20. The bioavailability of flufenamic acid from aluminum flufenamate tablet and flufenamic acid capsule, and the influence of food and aluminum hydroxide gel. Kaniwa N; Ogata H; Aoyagi N; Ejima A J Pharmacobiodyn; 1982 Mar; 5(3):187-92. PubMed ID: 7097486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]